Scientists shrink pancreatic tumors by starving their cellular “neighbors”

Scientists demonstrated for the first time that blocking “cell drinking,” or macropinocytosis, in the thick tissue surrounding a pancreatic tumor slowed tumor growth.

Leprosy drug holds promise as at-home treatment for COVID-19

Phase 2 clinical trial could begin immediately for clofazimine, an FDA-approved drug on WHO’s List of Essential Medicines.

In Pancreatic Cancer, New Biomarker May Predict Benefit of Tumor-Penetrating PeptideIn Pancreatic Cancer, New Biomarker May Predict Benefit of Tumor-Penetrating Peptide

In experiments with models of pancreatic cancer, a cyclic peptide called iRGD was found to penetrate tumors via a molecular pathway mediated by β5 integrin. This protein may serve as a useful biomarker, one that could indicate which patients will respond best to iRGD-combination therapy.

Evan Snyder named Fellow of the American Institute for Medical and Biological Engineering

Renowned stem cell researcher recognized by his peers for seminal contributions to regenerative medicine.